Candida albicans plays a dynamic role in the complex ecosystem of the gut microbiota. While normally present in the gastrointestinal tract, an overgrowth of C. albicans, often referred to as intestinal candidiasis, can disrupt the balance of the gut microbiota. Factors such as a high-sugar diet, prolonged use of antibiotics, and immunosuppression can contribute to the proliferation of C. albicans in the gut. Imbalances in the gut microbiota, including an overgrowth of Candida, have been associated with various health issues, ranging from digestive problems to systemic effects on overall health. Some theories suggest a connection between gut dysbiosis and conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Maintaining a healthy gut microbiota involves dietary modifications, probiotic supplementation, and lifestyle changes. Research into the intricate interactions between Candida albicans and other microorganisms in the gut is ongoing, providing valuable insights into the potential links between gut health and various systemic conditions.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain